The role of baseline inflammatory-based scores and serum tumor markers to risk stratify pseudomyxoma peritonei patients treated with cytoreduction (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC)

S. Kusamura, D. Baratti, I. Hutanu, C. Gavazzi, D. Morelli, D. R. Iusco, A. Grassi, S. Bonomi, S. Virzì, E. Haeusler, M. Deraco

Research output: Contribution to journalArticle

Abstract

Aims Inflammation-based scores such as neutrophil-lymphocyte ratio (NLR) and Onodera nutritional index (ONI) have been identified as new prognosticators in several tumors. We conducted a prognostic analysis of these markers and performed a risk stratification of PMP patients submitted to cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC). Methods 226 patients from two peritoneal surface malignancies centers participated in this study. Cox proportional modeling was used to select predictors of overall survival (OS) among baseline inflammation-based scores, serum tumor markers, clinical and surgical variables. Risk stratification was done using conditional inference tree model. Results One hundred eighty-two cases had diffuse peritoneal adenomucinosis subtype. Fifty-four cases had received previous systemic chemotherapy. The means of ONI and NLR were 51.4 (SD = 9.8) and 3.2 (SD = 2.3), respectively. Two hundred ten cases were optimally cytoreduced. Cox analysis identified completeness of cytoreduction, histological subtype, previous systemic chemotherapy, NLR, and CA 19-9 as independent prognosticators. Conditional inference tree method identified two poor prognostic subsets: NLR ≤2.7 and CA 19-9 > 336 (5yr-OS = 15%) and NLR >2.7 and ONI ≤42 (5yr-OS = 30%). Conclusions NLR, ONI, and CA 19-9 are new prognosticators that contributed to improve prediction of OS in PMP patients treated by CRS and HIPEC. These markers allowed a risk stratification that could optimize therapeutic management of PMP patients.

Original languageEnglish
Article number4042
Pages (from-to)1097-1105
Number of pages9
JournalEuropean Journal of Surgical Oncology
Volume41
Issue number8
DOIs
Publication statusPublished - Aug 1 2015

Fingerprint

Pseudomyxoma Peritonei
Tumor Biomarkers
Nutrition Assessment
Neutrophils
Biomarkers
Drug Therapy
Lymphocytes
Survival
Inflammation
Lymphocyte Subsets
Neoplasms

Keywords

  • Cytoreductive surgery
  • Hyperthermic intraperitoneal chemotherapy
  • Inflammation-based scores
  • Prognosis
  • Pseudomyxoma peritonei

ASJC Scopus subject areas

  • Oncology
  • Surgery
  • Medicine(all)

Cite this

The role of baseline inflammatory-based scores and serum tumor markers to risk stratify pseudomyxoma peritonei patients treated with cytoreduction (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC). / Kusamura, S.; Baratti, D.; Hutanu, I.; Gavazzi, C.; Morelli, D.; Iusco, D. R.; Grassi, A.; Bonomi, S.; Virzì, S.; Haeusler, E.; Deraco, M.

In: European Journal of Surgical Oncology, Vol. 41, No. 8, 4042, 01.08.2015, p. 1097-1105.

Research output: Contribution to journalArticle

@article{e379557091ea4ef1baeed6c914a9cc07,
title = "The role of baseline inflammatory-based scores and serum tumor markers to risk stratify pseudomyxoma peritonei patients treated with cytoreduction (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC)",
abstract = "Aims Inflammation-based scores such as neutrophil-lymphocyte ratio (NLR) and Onodera nutritional index (ONI) have been identified as new prognosticators in several tumors. We conducted a prognostic analysis of these markers and performed a risk stratification of PMP patients submitted to cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC). Methods 226 patients from two peritoneal surface malignancies centers participated in this study. Cox proportional modeling was used to select predictors of overall survival (OS) among baseline inflammation-based scores, serum tumor markers, clinical and surgical variables. Risk stratification was done using conditional inference tree model. Results One hundred eighty-two cases had diffuse peritoneal adenomucinosis subtype. Fifty-four cases had received previous systemic chemotherapy. The means of ONI and NLR were 51.4 (SD = 9.8) and 3.2 (SD = 2.3), respectively. Two hundred ten cases were optimally cytoreduced. Cox analysis identified completeness of cytoreduction, histological subtype, previous systemic chemotherapy, NLR, and CA 19-9 as independent prognosticators. Conditional inference tree method identified two poor prognostic subsets: NLR ≤2.7 and CA 19-9 > 336 (5yr-OS = 15{\%}) and NLR >2.7 and ONI ≤42 (5yr-OS = 30{\%}). Conclusions NLR, ONI, and CA 19-9 are new prognosticators that contributed to improve prediction of OS in PMP patients treated by CRS and HIPEC. These markers allowed a risk stratification that could optimize therapeutic management of PMP patients.",
keywords = "Cytoreductive surgery, Hyperthermic intraperitoneal chemotherapy, Inflammation-based scores, Prognosis, Pseudomyxoma peritonei",
author = "S. Kusamura and D. Baratti and I. Hutanu and C. Gavazzi and D. Morelli and Iusco, {D. R.} and A. Grassi and S. Bonomi and S. Virz{\`i} and E. Haeusler and M. Deraco",
year = "2015",
month = "8",
day = "1",
doi = "10.1016/j.ejso.2015.04.005",
language = "English",
volume = "41",
pages = "1097--1105",
journal = "European Journal of Surgical Oncology",
issn = "0748-7983",
publisher = "W.B. Saunders Ltd",
number = "8",

}

TY - JOUR

T1 - The role of baseline inflammatory-based scores and serum tumor markers to risk stratify pseudomyxoma peritonei patients treated with cytoreduction (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC)

AU - Kusamura, S.

AU - Baratti, D.

AU - Hutanu, I.

AU - Gavazzi, C.

AU - Morelli, D.

AU - Iusco, D. R.

AU - Grassi, A.

AU - Bonomi, S.

AU - Virzì, S.

AU - Haeusler, E.

AU - Deraco, M.

PY - 2015/8/1

Y1 - 2015/8/1

N2 - Aims Inflammation-based scores such as neutrophil-lymphocyte ratio (NLR) and Onodera nutritional index (ONI) have been identified as new prognosticators in several tumors. We conducted a prognostic analysis of these markers and performed a risk stratification of PMP patients submitted to cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC). Methods 226 patients from two peritoneal surface malignancies centers participated in this study. Cox proportional modeling was used to select predictors of overall survival (OS) among baseline inflammation-based scores, serum tumor markers, clinical and surgical variables. Risk stratification was done using conditional inference tree model. Results One hundred eighty-two cases had diffuse peritoneal adenomucinosis subtype. Fifty-four cases had received previous systemic chemotherapy. The means of ONI and NLR were 51.4 (SD = 9.8) and 3.2 (SD = 2.3), respectively. Two hundred ten cases were optimally cytoreduced. Cox analysis identified completeness of cytoreduction, histological subtype, previous systemic chemotherapy, NLR, and CA 19-9 as independent prognosticators. Conditional inference tree method identified two poor prognostic subsets: NLR ≤2.7 and CA 19-9 > 336 (5yr-OS = 15%) and NLR >2.7 and ONI ≤42 (5yr-OS = 30%). Conclusions NLR, ONI, and CA 19-9 are new prognosticators that contributed to improve prediction of OS in PMP patients treated by CRS and HIPEC. These markers allowed a risk stratification that could optimize therapeutic management of PMP patients.

AB - Aims Inflammation-based scores such as neutrophil-lymphocyte ratio (NLR) and Onodera nutritional index (ONI) have been identified as new prognosticators in several tumors. We conducted a prognostic analysis of these markers and performed a risk stratification of PMP patients submitted to cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC). Methods 226 patients from two peritoneal surface malignancies centers participated in this study. Cox proportional modeling was used to select predictors of overall survival (OS) among baseline inflammation-based scores, serum tumor markers, clinical and surgical variables. Risk stratification was done using conditional inference tree model. Results One hundred eighty-two cases had diffuse peritoneal adenomucinosis subtype. Fifty-four cases had received previous systemic chemotherapy. The means of ONI and NLR were 51.4 (SD = 9.8) and 3.2 (SD = 2.3), respectively. Two hundred ten cases were optimally cytoreduced. Cox analysis identified completeness of cytoreduction, histological subtype, previous systemic chemotherapy, NLR, and CA 19-9 as independent prognosticators. Conditional inference tree method identified two poor prognostic subsets: NLR ≤2.7 and CA 19-9 > 336 (5yr-OS = 15%) and NLR >2.7 and ONI ≤42 (5yr-OS = 30%). Conclusions NLR, ONI, and CA 19-9 are new prognosticators that contributed to improve prediction of OS in PMP patients treated by CRS and HIPEC. These markers allowed a risk stratification that could optimize therapeutic management of PMP patients.

KW - Cytoreductive surgery

KW - Hyperthermic intraperitoneal chemotherapy

KW - Inflammation-based scores

KW - Prognosis

KW - Pseudomyxoma peritonei

UR - http://www.scopus.com/inward/record.url?scp=84943375831&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84943375831&partnerID=8YFLogxK

U2 - 10.1016/j.ejso.2015.04.005

DO - 10.1016/j.ejso.2015.04.005

M3 - Article

C2 - 26026742

AN - SCOPUS:84943375831

VL - 41

SP - 1097

EP - 1105

JO - European Journal of Surgical Oncology

JF - European Journal of Surgical Oncology

SN - 0748-7983

IS - 8

M1 - 4042

ER -